COPD trials in Brazil

In Brazil 20 Also abroad 559

20 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Not yet taking people in Brazil
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Where
São Paulo
Age
40 years and over
People
1,252
Run by
Eurofarma Laboratorios S.A.
See details and how to joinNCT06234345
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Belo Horizonte, Goiânia, Porto Alegre, São Bernardo do Campo, São Paulo
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
Phase 4Taking people
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Where
Feira de Santana, Goiânia, Porto Alegre, Salvador, São Paulo
Age
40 years to 85 years
People
218 worldwide
Run by
Sanofi
See details and how to joinNCT07053423
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Where
Brasília, Curitiba, Natal, Porto Alegre, Rio de Janeiro, São José do Rio Preto, São José dos Campos, São Paulo
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00
No phaseTaking people
Study That Will Evaluate the Brazilian Population With COPD.
Where
Aparecida de Goiânia, Bahia, Belém, Brasília, Campo Grande, Florianópolis, Goiânia, Santo André, São Paulo, Uberlândia
Age
18 years and over
People
693
Run by
AstraZeneca
See details and how to joinNCT06780046
No phaseTaking people
PBMT Associated With a Pulmonary Rehabilitation Program on the Functional Capacity of Patients With COPD
Where
Porto Alegre
Age
18 years to 90 years
People
20
Run by
Federal University of Health Science of Porto Alegre
See details and how to joinNCT07878884
No phaseNot yet taking people in Brazil
Effect of Dietary Fiber Supplementation on Systemic Inflammation and Clinical Parameters in COPD
Where
Belo Horizonte
Age
18 years to 75 years
People
100
Run by
Júnea Regina Pires Drews
See details and how to joinNCT07868211
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Belo Horizonte, Blumenau, Brasília, Campina Grande do Sul, Campinas, Caxias do Sul, Curitiba, Fortaleza, Ijuí, Juiz de Fora, Mossoró, Natal, Niterói, Passo Fundo, Porto Alegre, Recife, Rio de Janeiro, Salvador, Santo André, São Bernardo do Campo, São José do Rio Preto, São Paulo, Serra, Sorocaba, Volta Redonda, Votuporanga
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Where
Bragança Paulista, Brasília, Campinas, Chapecó, Curitiba, Jaú, Mossoró, Porto Alegre, Salvador, São José do Rio Preto, Vitória
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00
No phaseTaking people
Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients
Where
São Paulo
Age
40 years and over
People
396
Run by
Chiesi Farmaceutica Ltda.
See details and how to joinNCT07406048
No phaseNot yet taking people in Brazil
Functional Assessment and Pulmonary Rehabilitation: Challenges and Perspectives for Comprehensive Care
Where
Belém
Age
40 years and over
People
46
Run by
Universidade do Estado do Pará
See details and how to joinNCT07415746
No phaseNot yet taking people in Brazil
Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity (MARES3)
Where
São Carlos, São Paulo
Age
30 years and over
People
473
Run by
University College, London
See details and how to joinNCT07134855
No phaseNot yet taking people in Brazil
Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity
Where
São Carlos, São Paulo
Age
30 years and over
People
1,000
Run by
University College, London
See details and how to joinNCT07093021
No phaseTaking people
Mitigating Chronic Respiratory Disease Through the Lens of Multi-Morbidity
Where
São Carlos, São Paulo
Age
30 years and over
People
859
Run by
University College, London
See details and how to joinNCT07050823
No phaseTaking people
Prospective and Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil (SCOPe).
Where
São Paulo
Age
18 years and over
People
693
Run by
Hospital Israelita Albert Einstein
See details and how to joinNCT06724315
Phase 4Not yet taking people in Brazil
Effects of CreaSafe® on Kidney, Muscle, and Cardiopulmonary Function in Athletes and COPD Patients
Where
Anápolis
People
140
Run by
Federal University of São Paulo
See details and how to joinNCT06991426
No phaseEnrolling by invitation
Acute Effects of Inspiratory Muscle Training on Peripheral Muscle Metabolism and Autonomic Response in COPD Patients
Where
João Pessoa
Age
40 years to 75 years
People
30
Run by
Federal University of Paraíba
See details and how to joinNCT06827379
No phaseTaking people
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
Where
São Paulo
Age
18 years to 85 years
People
60
Run by
University of Sao Paulo General Hospital
See details and how to joinNCT06882265
No phaseTaking people
Effects of Elastic Tape on Pulmonary Rehabilitation of Patients with Chronic Obstructive Pulmonary Disease
Where
São Paulo
People
42
Run by
University of Sao Paulo General Hospital
See details and how to joinNCT05939999
Phase 2/3Taking people
Cell Therapy Associated With Endobronchial Valve
Where
Porto Alegre
Age
18 years and over
People
34
Run by
Hospital de Clinicas de Porto Alegre
See details and how to joinNCT04018729